Background illustration for clinical trials search

Paid Clinical Trials Glenview

Discover 2,388 paid clinical trials in Glenview, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

for
Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Location: Chicago IL, Indianapolis IN, Detroit MI, Minneapolis MN,
Sponsor: Insulet Corporation

Sex: All

Age: 14 - 70+

Code: NCT07579702

Recruiting

Trial in HPV Prevention for the U.S. Vietnamese Community

for
HPV-related Cancers, HPV Vaccination
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07637630

Recruiting

A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

for
Diabetic Foot Ulcers
Location: Chicago IL, Southfield MI, Hamilton, Kittaning PA,
Sponsor: SANUWAVE, Inc.

Sex: All

Age: 22+

Code: NCT01824407

Phase 3, Recruiting

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

for
Oral Squamous Cell Carcinoma
Location: Chicago IL, Cleveland OH, Miami FL, Duarte CA
Sponsor: Privo Technologies

Sex: All

Age: 18 - 70+

Code: NCT05893888

Phase 2, Phase 3, Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Chicago IL, Mukwonago WI, Rockford IL, Waukesha WI,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The REACH-OUT Trial

for
Hypertension, Reproductive Behavior, Primary Health Care,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 18 - 44

Code: NCT07540143

Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Chicago IL, Hinsdale IL, Bridgeton MO, Nashville TN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase 3, Recruiting

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

for
Acute Gastrointestinal Bleeding
Location: Chicago IL, Toronto, Piscataway NJ, New York NY,
Sponsor: Medtronic - MITG

Sex: All

Age: 22+

Code: NCT06188585

Recruiting

Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma

for
Metastatic NUT Carcinoma, Unresectable NUT Carcinoma
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07050186

Phase 2, Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

for
Metastatic Dedifferentiated Liposarcoma,
Location: Chicago IL, Orland Park IL, New Lenox IL, St Louis MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05711615

Phase 1, Recruiting

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

for
Stroke, Acute, Ischemic Stroke, Acute, Hemorrhagic Stroke
Location: Chicago IL, Ann Arbor MI, Cincinnati OH, Atlanta GA,
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06094478

Recruiting

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Chicago IL
Sponsor: Reem Karmali

Sex: All

Age: 18+

Code: NCT06723457

Phase 2, Recruiting

Hypofractionation (Radiation) Trial for Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06270888

Phase 1, Recruiting

Association of Near Infrared Spectroscopy With Interstage Outcomes

for
Single-ventricle
Location: Oak Lawn IL
Sponsor: Advocate Hospital System

Sex: All

Age: 0

Code: NCT06538571

Recruiting

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

for
Estrogen-receptor-positive Breast Cancer,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06062498

Phase 2, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Chicago IL, Milwaukee WI, Iowa City IA, Detroit MI,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

for
Buccal Mucosa Squamous Cell Carcinoma,
Location: Chicago IL, Oak Creek WI, New Berlin WI, Milwaukee WI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT04333537

Phase 2, Phase 3, Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

for
Relapsed Hematologic Malignancy,
Location: Chicago IL, Rochester MN, Cleveland OH, Pittsburgh PA,
Sponsor: Curis, Inc.

Sex: All

Age: 18+

Code: NCT03328078

Phase 1, Phase 2, Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: Chicago IL, St Louis MO, Saint Paul MN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase 2, Recruiting

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Chicago IL, Detroit MI, Cincinnati OH, St Louis MO,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07210723

Phase 2, Phase 3, Recruiting